Evidence map›Paper›PMID 37314870›Full record

ReviewPathologica2023

The ideal reporting of

Umberto Malapelle, Valentina Angerilli, Francesco Pepe, Gabriella Fontanini, Sara Lonardi, Mario Scartozzi, Lorenzo Memeo, Gianfranco Pruneri, Antonio Marchetti, Giuseppe Perrone and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Cancers · 2025
    Article
  3. International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Umberto MalapelleDepartment of Public Health, University of Naples Federico II, Naples (NA), Italy.
Valentina AngerilliDepartment of Medicine (DIMED), University of Padua, Padua (PD), Italy.
Francesco PepeDepartment of Public Health, University of Naples Federico II, Naples (NA), Italy.
Gabriella FontaniniDepartment of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa (PI), Italy.
Sara LonardiMedical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua (PD), Italy.
Mario ScartozziMedical Oncology, University Hospital and University of Cagliari, Cagliari (CA), Italy.
Lorenzo MemeoDepartment of Experimental Oncology, Mediterranean Institute of Oncology, Viagrande, Catania (CT), Italy.
Gianfranco PruneriDepartment of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, Milan (MI), Italy.
Antonio MarchettiCenter for Advanced Studies and Technology (CAST), University Chieti-Pescara, Chieti (CH), Italy.
Giuseppe Perrone *Department of Medicine and Surgery, Research Unit of Anatomical Pathology, Università Campus Bio-Medico di Roma, Roma, Italy.
Matteo Fassan *Department of Medicine (DIMED), University of Padua, Padua (PD), Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerscolorectal cancerprecision medicine

Identifiers

PMID37314870
PMCPMC10462993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.